Shuoshi Biotech announced that the company's product, the monkeypox virus nucleic acid detection kit, was included in the WHO emergency use list on December 3, and the procurement period is 1 year if there are no special circumstances. This shows that WHO's approval of the company's product can provide a basis for purchasers to promote and sell this product in overseas markets. However, there are deadlines and requirements for product inclusion. Actual sales are affected by factors such as overseas policies, demand, and competition. The scale of sales is uncertain, and it is currently impossible to predict the impact on future performance.

Shuoshi Biotech announced that the company's product, the monkeypox virus nucleic acid detection kit, was included in the WHO emergency use list on December 3, and the procurement period is 1 year if there are no special circumstances. This shows that WHO's approval of the company's product can provide a basis for purchasers to promote and sell this product in overseas markets. However, there are deadlines and requirements for product inclusion. Actual sales are affected by factors such as overseas policies, demand, and competition. The scale of sales is uncertain, and it is currently impossible to predict the impact on future performance.